CFX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 476.8 -- higher than 92.39% of US-listed equities with positive expected earnings growth.
With a year-over-year growth in debt of -43.45%, Colfax CORP's debt growth rate surpasses merely 7.34% of about US stocks.
Colfax CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 30.13%, greater than the shareholder yield of 92.91% of stocks in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to Colfax CORP are TEX, THR, ANDE, ENV, and CUB.
Colfax Corporation is a manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. The company was founded in 1860 and is based in Annapolis Junction, Maryland.
CFX Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Colfax CORP with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Colfax CORP ranked in the 10th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Colfax CORP, consider:
Its compound free cash flow growth rate, as measured over the past 5.52 years, is -0.17% -- higher than just 9.83% of stocks in our DCF forecasting set.
Colfax CORP's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 70.62% of tickers in our DCF set.
Relative to other stocks in its sector (Industrials), Colfax CORP has a reliance on debt greater than 65.94% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Colfax CORP? See FLOW, ACM, AIR, BKNG, and GLG.
DJO, a subsidiary of Colfax (CFX), acquires Trilliant Surgical, a national provider of foot and ankle orthopedic implants.In addition to having a broad product portfolio covering the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System™.The acquisition supports DJO’s expansion...
In reconstruction, the torn ligament is removed and replaced with a piece of tendon from another part of the knee or from a deceased donor. This surgery is an outpatient procedure performed through small incisions around the knee joint and